Cargando…
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
BACKGROUND: No results of controlled trials are available for any of the few treatments offered to children with interstitial lung diseases (chILD). We evaluated hydroxychloroquine (HCQ) in a phase 2, prospective, multicentre, 1:1-randomized, double-blind, placebo-controlled, parallel-group/crossove...
Autores principales: | Griese, Matthias, Kappler, Matthias, Stehling, Florian, Schulze, Johannes, Baden, Winfried, Koerner-Rettberg, Cordula, Carlens, Julia, Prenzel, Freerk, Nährlich, Lutz, Thalmeier, Andreas, Sebah, Daniela, Kronfeld, Kai, Rock, Hans, Ruckes, Christian, Wetzke, Martin, Seidl, Elias, Schwerk, Nicolaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308121/ https://www.ncbi.nlm.nih.gov/pubmed/35871071 http://dx.doi.org/10.1186/s13023-022-02399-2 |
Ejemplares similares
-
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
por: Griese, Matthias, et al.
Publicado: (2020) -
Minimal important difference in childhood interstitial lung diseases
por: Griese, Matthias, et al.
Publicado: (2023) -
ABCA3-related interstitial lung disease beyond infancy
por: Li, Yang, et al.
Publicado: (2023) -
Trainability of Health-Related and Motor Performance Fitness in Adults with Cystic Fibrosis within a 12-Month Partially Supervised Exercise Program
por: Welsner, Matthias, et al.
Publicado: (2021) -
Effects of a Long-Term Monitored Exercise Program on Aerobic Fitness in a Small Group of Children with Cystic Fibrosis
por: Gruber, Wolfgang, et al.
Publicado: (2022)